These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 37291448

  • 41. Can Studies of Neuroinflammation in a TSPO Genetic Subgroup (HAB or MAB) Be Applied to the Entire AD Cohort?
    Fan Z, Harold D, Pasqualetti G, Williams J, Brooks DJ, Edison P.
    J Nucl Med; 2015 May; 56(5):707-13. PubMed ID: 25840980
    [Abstract] [Full Text] [Related]

  • 42. Kinetic modeling and non-invasive approach for translocator protein quantification with 11C-DPA-713.
    Yasuno F, Kimura Y, Ogata A, Ikenuma H, Abe J, Minami H, Nihashi T, Yokoi K, Hattori S, Shimoda N, Ichise M, Sakurai T, Ito K, Kato T.
    Nucl Med Biol; 2022 May; 108-109():76-84. PubMed ID: 35349913
    [Abstract] [Full Text] [Related]

  • 43. TSPO PET with [18F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis.
    Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL.
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. 18F-PBR111 PET Imaging in Healthy Controls and Schizophrenia: Test-Retest Reproducibility and Quantification of Neuroinflammation.
    Ottoy J, De Picker L, Verhaeghe J, Deleye S, Wyffels L, Kosten L, Sabbe B, Coppens V, Timmers M, van Nueten L, Ceyssens S, Stroobants S, Morrens M, Staelens S.
    J Nucl Med; 2018 Aug; 59(8):1267-1274. PubMed ID: 29326362
    [Abstract] [Full Text] [Related]

  • 50. Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging.
    Lavisse S, Goutal S, Wimberley C, Tonietto M, Bottlaender M, Gervais P, Kuhnast B, Peyronneau MA, Barret O, Lagarde J, Sarazin M, Hantraye P, Thiriez C, Remy P.
    Parkinsonism Relat Disord; 2021 Jan; 82():29-36. PubMed ID: 33242662
    [Abstract] [Full Text] [Related]

  • 51. Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism.
    Lee SH, Denora N, Laquintana V, Mangiatordi GF, Lopedota A, Lopalco A, Cutrignelli A, Franco M, Delre P, Song IH, Kim HW, Kim SB, Park HS, Kim K, Lee SY, Youn H, Lee BC, Kim SE.
    Eur J Nucl Med Mol Imaging; 2021 Dec; 49(1):110-124. PubMed ID: 34783879
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Characterization of the inflammatory post-ischemic tissue by full volumetric analysis of a multimodal imaging dataset.
    Barca C, Foray C, Hermann S, Döring C, Schäfers M, Jacobs AH, Zinnhardt B.
    Neuroimage; 2020 Nov 15; 222():117217. PubMed ID: 32745676
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Reliable quantification of 18F-GE-180 PET neuroinflammation studies using an individually scaled population-based input function or late tissue-to-blood ratio.
    Buchert R, Dirks M, Schütze C, Wilke F, Mamach M, Wirries AK, Pflugrad H, Hamann L, Langer LBN, Wetzel C, Lukacevic M, Polyak A, Kessler M, Petrusch C, Bengel FM, Geworski L, Rupprecht R, Weissenborn K, Ross TL, Berding G.
    Eur J Nucl Med Mol Imaging; 2020 Nov 15; 47(12):2887-2900. PubMed ID: 32322915
    [Abstract] [Full Text] [Related]

  • 56. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18F-VUIIS1018A) to Image Glioma.
    Tang D, Li J, Nickels ML, Huang G, Cohen AS, Manning HC.
    Mol Imaging Biol; 2019 Feb 15; 21(1):113-121. PubMed ID: 29869061
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA.
    Suridjan I, Rusjan PM, Kenk M, Verhoeff NP, Voineskos AN, Rotenberg D, Wilson AA, Meyer JH, Houle S, Mizrahi R.
    Synapse; 2014 Nov 15; 68(11):536-47. PubMed ID: 25043159
    [Abstract] [Full Text] [Related]

  • 59. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.
    Wang Y, Yue X, Kiesewetter DO, Niu G, Teng G, Chen X.
    Eur J Nucl Med Mol Imaging; 2014 Jul 15; 41(7):1440-9. PubMed ID: 24615467
    [Abstract] [Full Text] [Related]

  • 60. Comparison of high and low molar activity TSPO tracer [18F]F-DPA in a mouse model of Alzheimer's disease.
    Keller T, López-Picón FR, Krzyczmonik A, Forsback S, Takkinen JS, Rajander J, Teperi S, Dollé F, Rinne JO, Haaparanta-Solin M, Solin O.
    J Cereb Blood Flow Metab; 2020 May 15; 40(5):1012-1020. PubMed ID: 31142224
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.